Hepatic gene transfer in Neonatal mice by Adeno-associated virus serotype 8 vector

Human Gene Therapy

Volumn 23, Issue 5, 2012, Pages 533-539

  Wang, Lili ^a   Wang, Huan ^a,b   Bell, Peter ^a   McMenamin, Deirdre ^a   Wilson, James M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; GENOMIC DNA; NEUTRALIZING ANTIBODY; PARVOVIRUS VECTOR;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; GROUPS BY AGE; GROWTH RATE; LIVER; MALE; MOUSE; NEWBORN; NEWBORN PERIOD; NONHUMAN; SEROTYPE; TRANSGENE; TRANSGENICS; VIRAL GENE DELIVERY SYSTEM; VIRUS CAPSID;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CAPSID; DEPENDOVIRUS; FEMALE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; LIVER; MALE; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; TRANSDUCTION, GENETIC;

ADENO-ASSOCIATED VIRUS; ANIMALIA; MIRIDAE; MUS;

EID: 84861715230     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2011.183     Document Type: Article

References (34)

1. Bell, P., Moscioni, A.D., McCarter, R.J., et al. (2006). Analysis of tumors arising in male B6C3F1 mice with and without AAV vector delivery to liver. Mol. Ther. 14, 34-44. (Pubitemid 43922140)
2. Calcedo, R., Vandenberghe, L.H., Gao, G., et al. (2009). Worldwide epidemiology of neutralizing antibodies to adenoassociated viruses. J. Infect. Dis. 199, 381-390.
3. Carbonaro, D.A., Jin, X., Petersen, D., et al. (2006). In vivo transduction by intravenous injection of a lentiviral vector expressing human ADA into neonatal ADA gene knockout mice: A novel form of enzyme replacement therapy for ADA deficiency. Mol. Ther. 13, 1110-1120. (Pubitemid 43779186)
4. Carrillo-Carrasco, N., Chandler, R.J., Chandrasekaran, S., et al. (2010). Liver-directed recombinant adeno-associated viral gene delivery rescues a lethal mouse model of methylmalonic acidemia and provides long-term phenotypic correction. Hum. Gene Ther. 21, 1147-1154.
5. Chandler, R.J., and Venditti, C.P. (2010). Long-term rescue of a lethal murine model of methylmalonic acidemia using adenoassociated viral gene therapy. Mol. Ther. 18, 11-16.
6. Chandler, R.J., Chandrasekaran, S., Carrillo-Carrasco, N., et al. (2011). Adeno-associated virus serotype 8 gene transfer rescues a neonatal lethal murine model of propionic acidemia. Hum. Gene Ther. 22, 477-481.
7. Cotugno, G., Annunziata, P., Tessitore, A., et al. (2011). Longterm amelioration of feline mucopolysaccharidosis VI After AAV-mediated liver gene transfer. Mol. Ther. 19, 461-469.
8. Cunningham, S.C., Dane, A.P., Spinoulas, A., et al. (2008). Gene delivery to the juvenile mouse liver using AAV2/8 vectors. Mol. Ther. 16, 1081-1088. (Pubitemid 351737073)
9. Daly, T.M. (2004). AAV-mediated gene transfer to the liver. Methods Mol. Biol. 246, 195-199.
10. Daly, T.M., Ohlemiller, K.K., Roberts, M.S., et al. (2001). Prevention of systemic clinical disease in MPS VII mice following AAV-mediated neonatal gene transfer. Gene Ther. 8, 1291-1298. (Pubitemid 32834297)
11. De, B.P., Heguy, A., Hackett, N.R., et al. (2006). High levels of persistent expression of a1-antitrypsin mediated by the nonhuman primate serotype rh.10 adeno-associated virus despite preexisting immunity to common human adeno-associated viruses. Mol. Ther. 13, 67-76. (Pubitemid 41763484)
12. Gao, G., Vandenberghe, L.H., Alvira, M.R., et al. (2004). Clades of adeno-associated viruses are widely disseminated in human tissues. J. Virol. 78, 6381-6388. (Pubitemid 38715936)
13. Gao, G., Lu, Y., Calcedo, R., et al. (2006). Biology of AAV serotype vectors in liver-directed gene transfer to nonhuman primates. Mol. Ther. 13, 77-87. (Pubitemid 41763485)
14. Gao, G.P., Alvira, M.R., Wang, L., et al. (2002). Novel adenoassociated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. U.S.A. 99,11854-9. (Pubitemid 34994488)
15. Ginn, S.L., Liao, S.H., Dane, A.P., et al. (2010). Lymphomagenesis in SCID-X1 mice following lentivirus-mediated phenotype correction independent of insertional mutagenesis and cc overexpression. Mol. Ther. 18, 965-976.
16. Hacein-Bey-Abina, S., Garrigue, A., Wang, G.P., et al. (2008). Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J. Clin. Invest. 118, 3132-3142.
17. Hu, C., Busuttil, R.W., and Lipshutz, G.S. (2010). RH10 provides superior transgene expression in mice when compared with natural AAV serotypes for neonatal gene therapy. J. Gene Med. 12, 766-778.
18. Hu, C., Cela, R.G., Suzuki, M., et al. (2011). Neonatal helperdependent adenoviral vector gene therapy mediates correction of hemophilia A and tolerance to human factor VIII. Proc. Natl. Acad. Sci. U.S.A. 108, 2082-2087.
19. Kobayashi, H., Carbonaro, D., Pepper, K., et al. (2005). Neonatal gene therapy of MPS I mice by intravenous injection of a lentiviral vector. Mol. Ther. 11, 776-789. (Pubitemid 40567982)
20. McKay, T.R., Rahim, A.A., Buckley, S.M., et al. (2011). Perinatal gene transfer to the liver. Curr. Pharm. Des. 17, 2528-2541.
21. Nathwani, A.C., Cochrane, M., McIntosh, J., et al. (2009). Enhancing transduction of the liver by adeno-associated viral vectors. Gene Ther. 16, 60-69.
22. Ponder, K.P. (2007). Immunology of neonatal gene transfer. Curr. Gene Ther. 7, 403-410. (Pubitemid 47595782)
23. Traas, A.M., Wang, P., Ma, X., et al. (2007). Correction of clinical manifestations of canine mucopolysaccharidosis I with neonatal retroviral vector gene therapy. Mol. Ther. 15, 1423-1431. (Pubitemid 47099299)
24. Waddington, S.N., Kennea, N.L., Buckley, S.M., et al. (2004). Fetal and neonatal gene therapy: Benefits and pitfalls. Gene Ther. 11(Suppl. 1), S92-S97. (Pubitemid 39359453)
25. Wang, L., Wang, H., Bell, P., et al. (2010). Systematic evaluation of AAV vectors for liver directed gene transfer in murine models. Mol. Ther. 18, 118-125.
26. Wang, L., Bell, P., Lin, J., et al. (2011a). AAV8-mediated hepatic gene transfer in infant rhesus monkeys (Macaca mulatta). Mol. Ther. 19, 2012-2020.
27. Wang, L., Calcedo, R., Bell, P., et al. (2011b). Impact of preexisting immunity on gene transfer to nonhuman primate liver with adeno-associated virus 8 vectors. Hum. Gene Ther. 22, 1389-1401.
28. Wang, L., Wang, H., Morizono, H., et al. (2011c). Sustained correction of OTC deficiency in spfash mice using optimized self-complementary AAV2/8 vectors. Gene Ther. [Epub ahead of print]
29. Wang, Z., Ma, H.I., Li, J., et al. (2003). Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Gene Ther. 10, 2105-2111. (Pubitemid 37536759)
30. Wang, Z., Zhu, T., Qiao, C., et al. (2005). Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat. Biotechnol. 23, 321-328. (Pubitemid 41094420)
31. Weinstein, D.A., Correia, C.E., Conlon, T., et al. (2010). Adenoassociated virus-mediated correction of a canine model of glycogen storage disease type Ia. Hum. Gene Ther. 21, 903-910.
32. Yiu, W.H., Lee, Y.M., Peng, W.T., et al. (2010). Complete normalization of hepatic G6PC deficiency in murine glycogen storage disease type Ia using gene therapy. Mol. Ther. 18, 1076-1084.
33. Yoshimitsu, M., Sato, T., Tao, K., et al. (2004). Bioluminescent imaging of a marking transgene and correction of Fabry mice by neonatal injection of recombinant lentiviral vectors. Proc. Natl. Acad. Sci. U.S.A. 101, 16909-16914. (Pubitemid 39601337)
34. Zhang, J., Xu, L., Haskins, M.E., et al. (2004). Neonatal gene transfer with a retroviral vector results in tolerance to human factor IX in mice and dogs. Blood 103, 143-151. (Pubitemid 38029930)